Anthony Brozusky - Principle Associate of Donor Operations Quality Assurance - Seres Therapeutics | LinkedIn
![C76 hal-williams-eric-meola-joe-carter-aki-avni-scott-cepicky-gary-talley-david-lander-dj-qualls-michael-bradley-angelique-kidjo C76 hal-williams-eric-meola-joe-carter-aki-avni-scott-cepicky-gary-talley-david-lander-dj-qualls-michael-bradley-angelique-kidjo](https://cdn.slidesharecdn.com/ss_thumbnails/c1-maria-sebaldt-apollonia-kotero-mark-traynowicz-buzz-bissinger-gerhard-casper-harry-monty-debra-fe-140207034906-phpapp01-thumbnail.jpg?w=3840&q=90)
C76 hal-williams-eric-meola-joe-carter-aki-avni-scott-cepicky-gary-talley-david-lander-dj-qualls-michael-bradley-angelique-kidjo
Full article: Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule
![James KARLSEN | Professor (Full) | PhD | Universitetet i Agder, Kristiansand | UIA | Department of Working Life and Innovation | Research profile James KARLSEN | Professor (Full) | PhD | Universitetet i Agder, Kristiansand | UIA | Department of Working Life and Innovation | Research profile](https://i1.rgstatic.net/ii/profile.image/415933752463362-1476177742330_Q512/James-Karlsen.jpg)